Company announcements

Dealing in securities

October 02, 2020

---

Johannesburg, Friday, 02 October 2020. Following the announcement on 30 September 2020 of the resignation of directors and in compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information is disclosed:

A. VESTING IN SHARE APPRECIATION RIGHTS AND SALE OF ORDINARY SHARES BY DIRECTOR PRIOR TO RESIGNATION

The following transactions are disclosed in relation to SARS:   

1.Name of director:	F Abbott
Nature of transaction:	The off-market issuance of shares to settle SARS
Date of vesting of SARS issued in 2014:	17 November 2019
Number of 2014 SARS vested to date:	21 208
2014 SARS issue value per share:	R18.41
1-day Volume Weighted Average price of shares	R87.60
Nature of transaction:	On market sale of shares
Number of ordinary shares issued to settle 2014 SARS:	16 751
Date of sale:	29 September 2020
Selling price per share:	R91.42
Day highest sale price:	R93.41
Day lowest sale price:	R89.33
Proceeds for total on market sale:	R1 531 376.42
Class of Securities:	Ordinary Shares
Nature and extent of prescribed officer’s interest:;	Direct beneficial

Prior clearance was obtained in respect of the above dealings by the director.

For more details contact:

Marian van der Walt
Senior Group Executive: Enterprise Risk and Investor Relations
+27(0)82 888 1242 (mobile)

Max Manoeli
Senior Investor Relations Coordinator
+27(0)82 759 1775 (mobile)

Johannesburg, South Africa
2 October 2020

Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited